Neoadjuvant chemotherapy for stage III and IV epithelial ovarian cancer: A comparative study.

被引：0
|
作者：
Loizzi, V
Cormio, G
Di Vagno, G
Resta, L
Cazzolla, A
Di Gilio, A
Cuccovillo, A
Selvaggi, L
机构：
[1] Univ Bari, Dept Ob Gyn, Bari, Italy
[2] Univ Bari, Dept Pathol, Bari, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5117
引用
收藏
页码：478S / 478S
页数：1
相关论文
共 50 条
  • [31] Paclitaxel and carboplatin as outpatient therapy for stage III and IV epithelial ovarian cancer
    Balbi, GC
    Menditto, A
    Calabria, G
    Musone, R
    Di Prisco, L
    Cassese, E
    Balbi, C
    Cardone, A
    PANMINERVA MEDICA, 2001, 43 (04) : 263 - 265
  • [32] Neoadjuvant chemotherapy in stage III breast cancer
    Alassas, M
    Chu, QY
    Burton, G
    Ampil, F
    Mizell, J
    Li, BD
    AMERICAN SURGEON, 2005, 71 (06) : 487 - 492
  • [33] Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer
    Mackay, Helen J.
    Brady, Mark F.
    Oza, Amit M.
    Reuss, Alexander
    Pujade-Lauraine, Eric
    Swart, Ann M.
    Siddiqui, Nadeem
    Colombo, Nicoletta
    Bookman, Michael A.
    Pfisterer, Jacobus
    du Bois, Andreas
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (06) : 945 - 952
  • [34] Racial disparities in women with stage IIIC and IV epithelial ovarian cancer receiving neoadjuvant chemotherapy versus primary debulking surgery: A National Cancer Database study
    Whitmore, G. T.
    Ramzan, A. A.
    Sheeder, J.
    Guntupalli, S. R.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 121 - 122
  • [35] Neoadjuvant and definitive chemotherapy or chemoradiation for stage III and IV vulvar cancer: A pooled Reanalysis
    Forner, Dirk Michael
    Mallmann, Peter
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2017, 212 : 115 - 118
  • [36] Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma
    Venkatramani, R.
    Stein, J. E.
    Sapra, A.
    Genyk, Y.
    Jhaveri, V.
    Malogolowkin, M.
    Mascarenhas, L.
    BRITISH JOURNAL OF SURGERY, 2015, 102 (01) : 108 - 113
  • [37] The use of cisplatin plus doxorubicin or paclitaxel in hyperthermic intraperitoneal chemotherapy (HIPEC) for stage IIIC or IV epithelial ovarian cancer: a comparative study
    Manzanedo, I.
    Pereira, F.
    Serrano, A.
    Perez-Viejo, E.
    Martinez-Torres, B.
    Carrion, L.
    Calzas, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (10): : 1357 - 1363
  • [38] The use of cisplatin plus doxorubicin or paclitaxel in hyperthermic intraperitoneal chemotherapy (HIPEC) for stage IIIC or IV epithelial ovarian cancer: a comparative study
    I. Manzanedo
    F. Pereira
    Á. Serrano
    E. Pérez-Viejo
    B. Martínez-Torres
    L. Carrión
    J. Calzas
    Clinical and Translational Oncology, 2019, 21 : 1357 - 1363
  • [39] Neoadjuvant chemotherapy and cytoreductive surgery in epithelial ovarian cancer
    Siriwan Tangjitgamol
    Jitti Hanprasertpong
    Marta Cubelli
    Claudio Zamagni
    World Journal of Obstetrics and Gynecology, 2013, (04) : 153 - 166
  • [40] Role of Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer
    du Bois, Andreas
    Baert, Thais
    Vergote, Ignace
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27) : 2398 - +
12345